Center for Personalized Medicine researchers recently launched the first clinical trial to investigate a genetic risk score test to predict patients’ risk of breast, prostate and colon cancer. Developed at NorthShore, the test is designed to help primary care physicians better understand how to prevent and treat cancer and how patients respond after learning of their increased risk. “Genetic information can be a powerful tool in understanding risk and recommending earlier screenings, especially when utilized at patients’ main access points to healthcare—primary care physicians,” said Peter Hulick, MD, recently named Medical Director for NorthShore’s Center for Personalized Medicine, who holds an academic appointment at the University of Chicago Pritzker School of Medicine.
Published by Staywell/NorthShore University. View All Articles.
This page can be found at http://mydigimag.rrd.com/article/Scoring+Your+Genetic+Risk+for+Disease/2641952/358626/article.html.